FlexDex

FlexDex is a medical device company developing mechanical surgical instruments for minimally invasive surgery (MIS). The company's proprietary technology translates the surgeon's hand, wrist, and arm movements from outside the patient into corresponding movements of an end-effector inside the patient's body, enhancing the capabilities of minimally invasive instruments and endoscopes. Unlike traditional robotic surgical systems that are expensive and complex, FlexDex offers a simpler, more affordable mechanical approach that provides surgeons with intuitive dexterity and precision control. The device aims to make advanced minimally invasive surgical techniques more accessible to hospitals and all sizes and Founded in 2010 and headquartered in Niagara, United States, FlexDex has raised approximately $39.6 million in Series C funding from investors including the National Science Foundation, Johnson & Johnson Innovation, and Almeda Ventures.